- Home
- CGEM vs SATL Comparison
CGEM vs SATL Comparison
Compare CGEM & SATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- SATL
- Stock Information
- Founded
- CGEM 2016
- SATL 2010
- Country
- CGEM United States
- SATL United States
- Employees
- CGEM N/A
- SATL N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- SATL Radio And Television Broadcasting And Communications Equipment
- Sector
- CGEM Health Care
- SATL Technology
- Exchange
- CGEM Nasdaq
- SATL Nasdaq
- Market Cap
- CGEM 437.2M
- SATL 373.7M
- IPO Year
- CGEM 2021
- SATL N/A
- Fundamental
- Price
- CGEM $8.49
- SATL $1.90
- Analyst Decision
- CGEM Strong Buy
- SATL
- Analyst Count
- CGEM 7
- SATL 0
- Target Price
- CGEM $26.00
- SATL N/A
- AVG Volume (30 Days)
- CGEM 1.5M
- SATL 7.0M
- Earning Date
- CGEM 11-07-2025
- SATL 11-12-2025
- Dividend Yield
- CGEM N/A
- SATL N/A
- EPS Growth
- CGEM N/A
- SATL N/A
- EPS
- CGEM N/A
- SATL N/A
- Revenue
- CGEM N/A
- SATL $13,868,000.00
- Revenue This Year
- CGEM N/A
- SATL N/A
- Revenue Next Year
- CGEM N/A
- SATL N/A
- P/E Ratio
- CGEM N/A
- SATL N/A
- Revenue Growth
- CGEM N/A
- SATL 1.09
- 52 Week Low
- CGEM $5.68
- SATL $0.93
- 52 Week High
- CGEM $17.50
- SATL $5.49
- Technical
- Relative Strength Index (RSI)
- CGEM 62.54
- SATL 29.45
- Support Level
- CGEM $7.69
- SATL $2.12
- Resistance Level
- CGEM $8.69
- SATL $2.33
- Average True Range (ATR)
- CGEM 0.65
- SATL 0.33
- MACD
- CGEM 0.06
- SATL -0.15
- Stochastic Oscillator
- CGEM 72.76
- SATL 1.43
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.